Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s277, 2023. DOI: 10.25251/skin.7.supp.277. Disponível em: https://skin.dermsquared.com/skin/article/view/2353. Acesso em: 23 may. 2026.